(0.07%) 5 250.00 points
(0.01%) 39 644 points
(0.16%) 18 284 points
(0.15%) $78.38
(1.38%) $2.28
(-0.87%) $2 354.40
(-0.56%) $28.35
(-0.17%) $1 005.50
(-0.04%) $0.928
(0.31%) $10.87
(0.00%) $0.798
(-0.87%) $91.87
Live Chart Being Loaded With Signals
ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors...
Stats | |
---|---|
Today's Volume | 1.17M |
Average Volume | 615 080 |
Market Cap | 356.10M |
EPS | $0 ( 2024-05-06 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.550 |
ATR14 | $0.00800 (0.19%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-08 | Redmile Group, Llc | Buy | 8 163 265 | Pre-Funded Warrants |
2024-05-08 | Redmile Group, Llc | Buy | 6 107 181 | Pre-Funded Warrants |
2024-05-07 | Mallik Ameet | Sell | 29 731 | Common Shares |
2024-01-03 | Redmile Group, Llc | Sell | 59 986 | Cash-settled Swaps |
2024-02-01 | Redmile Group, Llc | Sell | 19 700 | Cash-settled Swaps |
INSIDER POWER |
---|
58.04 |
Last 79 transactions |
Buy: 16 087 938 | Sell: 5 200 810 |
Volume Correlation
ADC Therapeutics SA Correlation
10 Most Positive Correlations | |
---|---|
PGTI | 0.961 |
ESMT | 0.961 |
IHTA | 0.953 |
AYX | 0.95 |
NEWR | 0.948 |
K | 0.945 |
IHC | 0.942 |
NKX | 0.942 |
JWN | 0.941 |
TCN | 0.939 |
10 Most Negative Correlations | |
---|---|
FLRT | -0.949 |
CANE | -0.944 |
SLB | -0.944 |
OII | -0.943 |
NVVE | -0.942 |
IEZ | -0.94 |
OIH | -0.937 |
WHD | -0.937 |
HAL | -0.935 |
FNGD | -0.935 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
ADC Therapeutics SA Correlation - Currency/Commodity
ADC Therapeutics SA Financials
Annual | 2023 |
Revenue: | $69.56M |
Gross Profit: | $67.03M (96.36 %) |
EPS: | $-2.94 |
FY | 2023 |
Revenue: | $69.56M |
Gross Profit: | $67.03M (96.36 %) |
EPS: | $-2.94 |
FY | 2022 |
Revenue: | $209.91M |
Gross Profit: | $205.33M (97.82 %) |
EPS: | $-1.990 |
FY | 2021 |
Revenue: | $33.92M |
Gross Profit: | $32.52M (95.89 %) |
EPS: | $-3.52 |
Financial Reports:
No articles found.
ADC Therapeutics SA
ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma; Phase III clinical trial in combination with rituximab to treat relapsed or refractory DLBCL in second-line transplant-ineligible patients; and Phase I clinical trial for treatment of relapsed or refractory non-hodgkin lymphoma (NHL). The company is also developing camidanlumab tesirine, an ADC that has completed Phase I clinical trial to treat relapsed or refractory NHL; in Phase II clinical trial in relapsed or refractory hodgkin lymphoma; and in Phase Ib clinical trial for selected advanced solid tumors. In addition, it develops ADCT-602, which is in Phase Ia clinical trial for treatment of acute lymphoblastic leukemia; ADCT-601 and ADCT-901 that are in Phase Ia clinical trial for treatment of various solid tumors; and preclinical product candidates, including ADCT-701 and ADCT-901 for the treatment of solid tumors. It has a collaboration and license agreement with Genmab A/S, Bergenbio AS, Synaffix B.V., Mitsubishi Tanabe Pharma Corporation, Overland Pharmaceuticals, and MedImmune Limited. ADC Therapeutics SA was incorporated in 2011 and is headquartered in Epalinges, Switzerland.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators